C-CAST: Executive Interview, CEO Kazuo Nakamura
Executive interview with CMIC Group’s CEO & Founder, Kazuo Nakamura
- Company Introduction
- Establishment of CMIC Group
- Company Vision
Representative Director, Chairman and CEO
Dr. Nakamura is our Chairman and CEO. He started a first CRO in Japan in 1992 and greatly contributed to found the Japan CRO Association with three other companies working in the field at that time Dr. Nakamura served as secretariat for 5 years from its establishment. As a chairman of the Japan CRO Association from 1999 until 2002, Dr. Nakamura dedicated his time and broad network in this industry to expand the Association and the CRO industry in Japan as a whole. The history of CMIC directly reflects the history of CROs in Japan. Prior to founding CMIC, Dr. Nakamura was a project team leader of the development of Pravastatin, a blockbuster drug primarily used for the treatment of dyslipidemia and the prevention of cardiovascular disease, in Sankyo Co., Ltd.
Dr. Nakamuara earned his bachelor’s degree from Faculty of Pharmaceutical Sciences, Kyoto University and doctoral degree from Graduate School of Natural Science & Technology, Kanazawa University.
Dr. Nakamura said, “CMIC Group pioneered the CRO business in Japan. We started out to support the development of pharmaceuticals, and it now offers greatly expanded services that encompass an entire value-chain of pharmaceutical companies, including manufacturing, sales, and marketing, based on our unique “Pharmaceutical Value Creator (PVC)” business model. We also offer services to medical device manufacturers, academia, bio-ventures, and medical institutions. We also provide prophylaxis and health enhancing services to the public. We will continue to establish business models that create further value and contribute to greater advances in the pharmaceutical industry.”